Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:1930-1932
Published online before print October 6, 2003, doi: 10.1161/01.CIR.0000096055.62724.C5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/16/1930    most recent
01.CIR.0000096055.62724.C5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calabró, P.
Right arrow Articles by Yeh, E. T.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calabró, P.
Right arrow Articles by Yeh, E. T.H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Smooth muscle proliferation and differentiation
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2003;108:1930.)
© 2003 American Heart Association, Inc.


Brief Rapid Communications

Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells

Paolo Calabró, MD; James T. Willerson, MD; Edward T.H. Yeh, MD

From the Department of Cardiology, University of Texas-M.D. Anderson Cancer Center (E.T.H.Y.), the University of Texas-Houston Health Science Center (P.C., J.T.W., E.T.H.Y.), and Texas Heart Institute, St Luke’s Episcopal Hospital (P.C., J.T.W., E.T.H.Y.), Houston, Tex.

Correspondence to Edward T.H. Yeh, MD, Department of Cardiology, 1515 Holcombe Blvd, Box 449, University of Texas-M.D. Anderson Cancer Center, Houston, TX 77030-4095. E-mail etyeh{at}mdanderson.org

Received June 26, 2003; de novo received August 6, 2003; revision received August 26, 2003; accepted August 26, 2003.

Background— Serum C-reactive protein (CRP) levels are good predictors of the development of cardiovascular events in apparently healthy men and women. CRP has been believed to be produced exclusively by hepatocytes during the acute-phase response. Several lines of evidence have suggested that atherosclerotic arteries can also produce CRP. However, the cell types that produce CRP locally in the atherosclerotic arterial wall have not been clearly identified.

Methods and Results— Human coronary artery smooth muscle cells (HCASMCs) and human umbilical vein endothelial cells (HUVECs) were incubated with interleukin-1ß (IL-1ß), IL-6, their combination, tumor necrosis factor-{alpha} (TNF-{alpha}), or lipopolysaccharide (LPS) at different concentrations. The supernatants were concentrated and analyzed by a high-sensitivity enzyme-linked immunosorbent assay specific for human CRP. RNA was extracted from the HCASMCs for reverse transcriptase-polymerase chain reaction (RT-PCR) using specific primers for the CRP. Maximal CRP production was observed in HCASMCs after 48 hours of incubation with the combination of 25 ng/mL of IL-1ß and 10 ng/mL of IL-6, whereas incubation with IL-1ß or IL-6 alone only modestly induced CRP. Incubation with TNF-{alpha} (50 ng/mL) or LPS (1000 EU/mL) resulted in an increase in CRP production comparable to the IL-1ß and IL-6 combination. The induction of CRP in HCASMCs was independently confirmed by RT-PCR comparing the relative CRP mRNA levels. The induction of CRP production by HCASMCs was not reproduced in HUVECs, however.

Conclusions— These results demonstrated that HCASMCs, but not HUVECs, could produce CRP in response to inflammatory cytokines. The locally produced CRP could directly participate in atherogenesis and the development of cardiovascular complications.


Key Words: atherosclerosis • inflammation • muscle, smooth • interleukins • risk factors




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Largo, M. J. Martinez-Calatrava, O. Sanchez-Pernaute, M. E. Marcos, J. Moreno-Rubio, C. Aparicio, J. Egido, and G. Herrero-Beaumont
Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H268 - H276.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. K. Hothi, L. Rees, J. Marek, J. Burton, and C. W. McIntyre
Pediatric Myocardial Stunning Underscores the Cardiac Toxicity of Conventional Hemodialysis Treatments
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 790 - 797.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
O. K. Chun, S.-J. Chung, K. J. Claycombe, and W. O. Song
Serum C-Reactive Protein Concentrations Are Inversely Associated with Dietary Flavonoid Intake in U.S. Adults
J. Nutr., April 1, 2008; 138(4): 753 - 760.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Wang, D. Liao, U. Bharadwaj, M. Li, Q. Yao, and C. Chen
C-Reactive Protein Inhibits Cholesterol Efflux From Human Macrophage-Derived Foam Cells
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 519 - 526.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. S. Packard and P. Libby
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Clin. Chem., January 1, 2008; 54(1): 24 - 38.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
D. Lithgow, A. Nyamathi, D. Elashoff, O. Martinez-Maza, and C. Covington
C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors
Biol Res Nurs, October 1, 2007; 9(2): 108 - 116.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Memoli, A. Procino, P. Calabro, P. Esposito, G. Grandaliano, G. Pertosa, M. D. Prete, M. Andreucci, S. D. Lillo, G. Ferulano, et al.
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1030 - E1035.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Kuji, T. Masaki, L. Li, and A. K. Cheung
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft model
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2469 - 2475.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Singh, M. Hoffmann, R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers
Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): e302 - e307.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. J. Pussinen, K. Tuomisto, P. Jousilahti, A. S. Havulinna, J. Sundvall, and V. Salomaa
Endotoxemia, Immune Response to Periodontal Pathogens, and Systemic Inflammation Associate With Incident Cardiovascular Disease Events
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S. Norja, L. Nuutila, P. J Karhunen, and S. Goebeler
C-reactive protein in vulnerable coronary plaques
J. Clin. Pathol., May 1, 2007; 60(5): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Tabuchi, K. Inoue, H. Usui-Kataoka, K. Kobayashi, M. Teramoto, K. Takasugi, K. Shikata, M. Yamamura, K. Ando, K. Nishida, et al.
The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
J. Lipid Res., April 1, 2007; 48(4): 768 - 781.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Barac, U. Campia, and J. A. Panza
Methods for Evaluating Endothelial Function in Humans
Hypertension, April 1, 2007; 49(4): 748 - 760.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig and N. Khuseyinova
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Albert and P. M Ridker
C-Reactive Protein as a Risk Predictor: Do Race/Ethnicity and Gender Make a Difference?
Circulation, August 1, 2006; 114(5): e67 - e74.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Paffen and M. P.M. deMaat
C-reactive protein in atherosclerosis: A causal factor?
Cardiovasc Res, July 1, 2006; 71(1): 30 - 39.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. Hamer, E. Williams, R. Vuonovirta, P. Giacobazzi, E. L. Gibson, and A. Steptoe
The Effects of Effort-Reward Imbalance on Inflammatory and Cardiovascular Responses to Mental Stress
Psychosom Med, May 1, 2006; 68(3): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Okopien, R. Krysiak, and Z. S. Herman
Effects of Short-Term Fenofibrate Treatment on Circulating Markers of Inflammation and Hemostasis in Patients with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1770 - 1778.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Krupinski, M. M. Turu, J. Martinez-Gonzalez, A. Carvajal, J. O. Juan-Babot, E. Iborra, M. Slevin, F. Rubio, and L. Badimon
Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
Stroke, May 1, 2006; 37(5): 1200 - 1204.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Montaner, I. Fernandez-Cadenas, C. A. Molina, M. Ribo, R. Huertas, A. Rosell, A. Penalba, L. Ortega, P. Chacon, and J. Alvarez-Sabin
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke, May 1, 2006; 37(5): 1205 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Tsimikas, J. T. Willerson, and P. M. Ridker
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C19 - C31.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Skowasch, S Schrempf, C J Preusse, J A Likungu, A Welz, B Luderitz, and G Bauriedel
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins
Heart, April 1, 2006; 92(4): 495 - 498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. Jialal, S. Devaraj, U. Singh, J. Fan, and Y. E. Chen
Sources of CRP in Atherosclerotic Lesions
Am. J. Pathol., March 1, 2006; 168(3): 1054 - 1056.
[Full Text] [PDF]


Home page
CirculationHome page
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine
Inflammatory Biomarkers in Acute Coronary Syndromes: Part II: Acute-Phase Reactants and Biomarkers of Endothelial Cell Activation
Circulation, February 21, 2006; 113(7): e152 - e155.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Meuwissen, A C van der Wal, H W M Niessen, K T Koch, R J de Winter, C M van der Loos, S Z H Rittersma, S A J Chamuleau, J G P Tijssen, A E Becker, et al.
Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction
J. Clin. Pathol., February 1, 2006; 59(2): 196 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D.-H. Kang, S.-K. Park, I.-K. Lee, and R. J. Johnson
Uric Acid-Induced C-Reactive Protein Expression: Implication on Cell Proliferation and Nitric Oxide Production of Human Vascular Cells
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3553 - 3562.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
I. Ciubotaru, L. A. Potempa, and R. C. Wander
Production of Modified C-Reactive Protein in U937-Derived Macrophages
Experimental Biology and Medicine, November 1, 2005; 230(10): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Yung, R. C.W. Tsang, Y. Sun, J. K.H. Leung, and T. M. Chan
Effect of Human Anti-DNA Antibodies on Proximal Renal Tubular Epithelial Cell Cytokine Expression: Implications on Tubulointerstitial Inflammation in Lupus Nephritis
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3281 - 3294.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Wang, S. Oparil, Y.-F. Chen, M. A. McCrory, G. A. Skibinski, W. Feng, and A. J. Szalai
Estrogen Treatment Abrogates Neointima Formation in Human C-Reactive Protein Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2094 - 2099.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Feinbloom and K. A. Bauer
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. T.H. Yeh
A New Perspective on the Biology of C-Reactive Protein
Circ. Res., September 30, 2005; 97(7): 609 - 611.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Calabro, D. W. Chang, J. T. Willerson, and E. T.H. Yeh
Release of C-Reactive Protein in Response to Inflammatory Cytokines by Human Adipocytes: Linking Obesity to Vascular Inflammation
J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1112 - 1113.
[Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
M. B. Clearfield
C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease
J Am Osteopath Assoc, September 1, 2005; 105(9): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Devaraj, G. O'Keefe, and I. Jialal
Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Satoh, M. Nakamura, T. Akatsu, Y. Shimoda, I. Segawa, and K. Hiramori
C-reactive protein co-expresses with tumor necrosis factor-{alpha} in the myocardium in human dilated cardiomyopathy
Eur J Heart Fail, August 1, 2005; 7(5): 748 - 754.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Inoue, T. Kato, T. Uchida, M. Sakuma, A. Nakajima, M. Shibazaki, Y. Imoto, M. Saito, S. Hashimoto, Y. Hikichi, et al.
Local Release of C-Reactive Protein From Vulnerable Plaque or Coronary Arterial Wall Injured by Stenting
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. A. Nath, J. P. Grande, A. J. Croatt, E. Frank, N. M. Caplice, R. P. Hebbel, and Z. S. Katusic
Transgenic Sickle Mice Are Markedly Sensitive to Renal Ischemia-Reperfusion Injury
Am. J. Pathol., April 1, 2005; 166(4): 963 - 972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. K. Venugopal, S. Devaraj, and I. Jialal
Macrophage Conditioned Medium Induces the Expression of C-Reactive Protein in Human Aortic Endothelial Cells: Potential for Paracrine/Autocrine Effects
Am. J. Pathol., April 1, 2005; 166(4): 1265 - 1271.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Takeda, E. Suzuki, H. Satonaka, S. Oba, H. Nishimatsu, M. Omata, T. Fujita, R. Nagai, and Y. Hirata
Blockade of Endogenous Cytokines Mitigates Neointimal Formation in Obese Zucker Rats
Circulation, March 22, 2005; 111(11): 1398 - 1406.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Maier, L. A. Altwegg, R. Corti, S. Gay, M. Hersberger, F. E. Maly, G. Sutsch, M. Roffi, M. Neidhart, F. R. Eberli, et al.
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein
Circulation, March 22, 2005; 111(11): 1355 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Ivashchenko, F. Kramer, S. Schafer, A. Bucher, K. Veit, V. Hombach, A. Busch, O. Ritzeler, J. Dedio, and J. Torzewski
Protein Kinase C Pathway Is Involved in Transcriptional Regulation of C-Reactive Protein Synthesis in Human Hepatocytes
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 186 - 192.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Khreiss, L. Jozsef, L. A. Potempa, and J. G. Filep
Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood
Circulation, October 26, 2004; 110(17): 2713 - 2720.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. H. Schindler, E. U. Nitzsche, M. Olschewski, N. Magosaki, M. Mix, J. O. Prior, A. D. Facta, U. Solzbach, H. Just, and H. R. Schelbert
Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors
Circulation, August 31, 2004; 110(9): 1069 - 1075.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Bogaty, J. M. Brophy, M. Noel, L. Boyer, S. Simard, F. Bertrand, and G. R. Dagenais
Impact of Prolonged Cyclooxygenase-2 Inhibition on Inflammatory Markers and Endothelial Function in Patients With Ischemic Heart Disease and Raised C-Reactive Protein: A Randomized Placebo-Controlled Study
Circulation, August 24, 2004; 110(8): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Blaschke, D. Bruemmer, F. Yin, Y. Takata, W. Wang, M. C. Fishbein, T. Okura, J. Higaki, K. Graf, E. Fleck, et al.
C-Reactive Protein Induces Apoptosis in Human Coronary Vascular Smooth Muscle Cells
Circulation, August 3, 2004; 110(5): 579 - 587.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Jialal, S. Devaraj, and S. K. Venugopal
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Hypertension, July 1, 2004; 44(1): 6 - 11.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. M Ridker, N. J. Brown, D. E. Vaughan, D. G. Harrison, and J. L. Mehta
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Circulation, June 29, 2004; 109(25_suppl_1): IV-6 - IV-19.
[Full Text] [PDF]


Home page
CirculationHome page
P. M Ridker and N. Cook
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
Circulation, April 27, 2004; 109(16): 1955 - 1959.
[Abstract] [Full Text] [PDF]